Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Centre Henri Becquerel
Sarcoma Alliance for Research through Collaboration
Fred Hutchinson Cancer Center
Centre Hospitalier Universitaire, Amiens
Thomas Jefferson University
Thomas Jefferson University